Seguimiento farmacoterapéutico a hipertensos de 45 a 64 años de edad con losartán de 100 mg del Hospital Teófilo Dávila

Abstract

Hypertension (HBP) is a silent disease that causes millions of deaths worldwide, therefore, in our country Ecuador and El Oro province, every day is more common especially in the middle age (45-64 years) , therefore it is proposed as the main objective; perform a Pharmacotherapeutic Follow-up to hypertensive patients from 45 to 64 years of age, with administration of Losartan of 100 mg, at Teófilo Dávila Hospital in Machala to improve and control HT. The Losartan of 100 mg, prescribed by the doctor in the pharmacological treatment of the patient diagnosed as hypertensive, is a first-choice medication as indicated in the National Basic Table of Drugs, acts as a regulator of systolic and diastolic pressure thus maintaining , heart rate by 80%, so it is a very effective medication in patients of middle adulthood. The present investigation was carried out by means of a Longitudinal Descriptive study through a Pharmacotherapeutic follow-up in a sample of 50 patients attended in the cardiology offices with a diagnosis of arterial hypertension, with an age range of 45 to 64 years, and in addition to having his medication losartan of 100 mg, during the period from August 2018 to January 2019 in the Teófilo Dávila hospital in the city of Machala, province of El Oro. Through a Pharmacotherapeutic follow-up using the DADER method, accurate and necessary information was collected for the different phases of the method, a survey was applied to see the patient's knowledge about HTA and interviews after his appointment with the cardiologist. Based on this, an action plan was elaborated, which includes the registration, monitoring and evaluation of the therapeutic effects of the drug Losartan. The patients with the highest prevalence of hypertension were 64% female, with an average age of 60 years, and the association of this disease with diabetes mellitus is very frequent since they are factors that influence the quality of life of the patient. In addition, it has been proven with more than 50% that hypertension is inherited by hypertensive parents, but also continue to progress cases of hypertension due to environmental factors, such as salt intake, poor diet, sedentary lifestyle , smoking, among others. The evaluation of the negative results associated with the drugs with respect to the study drug meets the need and safety in its entirety to treat HT, but at the beginning of the investigation there was a non-quantitative ineffectiveness on the part of the patient when not taking the medication correctly, which was corrected and as a final result all patients take the correct dose.